• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与非感染性肺部并发症相关的常见可变免疫缺陷及其治疗:超越免疫球蛋白治疗

Common Variable Immunodeficiency Associated With Noninfectious Pulmonary Complications and Its Treatment: Beyond Immunoglobulin Therapy.

作者信息

Parsons Austin J, Franco-Palacios Domingo, Kelly Bryan, Grafton Gillian, McIntosh Javardo, Coleman David, Abdul Hameed Asif M, Sayf Alaa Abu

机构信息

Department of Internal Medicine Henry Ford Hospital Detroit Michigan USA.

Division of Pulmonary Medicine, Henry Ford Hospital Detroit Michigan USA.

出版信息

Pulm Circ. 2025 Jan 1;15(1):e70034. doi: 10.1002/pul2.70034. eCollection 2025 Jan.

DOI:10.1002/pul2.70034
PMID:39744645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11688575/
Abstract

Common variable immunodeficiency (CVID) is a type of primary immunodeficiency that presents as a heterogenous disorder characterized by hypogammaglobinemia, poor response to vaccines, recurrent sinopulmonary infections, and can have noninfectious systemic manifestations. We performed a single-center, retrospective, observational study of five patients with noninfectious complications of CVID. All patients had CVID as defined by the European Society of Immunodeficiencies criteria and had received intravenous immunoglobulin therapy. There were multiple pulmonary manifestations of CVID including frequent pneumonias, bronchiectasis, granulomatous lung disease, and pulmonary hypertension. All our patients were treated with pulmonary vasodilators for severe precapillary pulmonary hypertension along with individualized immunosuppression regimen for interstitial lung disease. Despite treatment for interstitial lung disease and PH, their conditions worsened over 2-3 years with all patients progressing toward organ transplant evaluation. Idiopathic thrombocytopenia and non-cirrhotic portal hypertension were common, with three patients probably suffering from nodular regenerative hyperplasia. Noninfectious complications of CVID can affect different organs and progress despite advanced therapies. Single or multiorgan transplantation is a treatment option for patients with end-stage organ involvement refractory to medical therapy.

摘要

普通可变免疫缺陷(CVID)是一种原发性免疫缺陷病,表现为一种异质性疾病,其特征为低丙种球蛋白血症、对疫苗反应不佳、反复发生鼻窦肺部感染,且可能有非感染性全身表现。我们对5例患有CVID非感染性并发症的患者进行了一项单中心、回顾性观察研究。所有患者均符合欧洲免疫缺陷学会标准所定义的CVID,并接受了静脉注射免疫球蛋白治疗。CVID有多种肺部表现,包括频繁肺炎、支气管扩张、肉芽肿性肺病和肺动脉高压。我们所有患者均接受了用于治疗重度毛细血管前肺动脉高压的肺血管扩张剂,以及针对间质性肺病的个体化免疫抑制方案。尽管对间质性肺病和肺动脉高压进行了治疗,但他们的病情在2至3年内仍恶化,所有患者都进展到需要进行器官移植评估。特发性血小板减少症和非肝硬化性门静脉高压很常见,有3例患者可能患有结节性再生性增生。尽管有先进的治疗方法,CVID的非感染性并发症仍可影响不同器官并进展。对于药物治疗难以控制的终末期器官受累患者,单器官或多器官移植是一种治疗选择。

相似文献

1
Common Variable Immunodeficiency Associated With Noninfectious Pulmonary Complications and Its Treatment: Beyond Immunoglobulin Therapy.与非感染性肺部并发症相关的常见可变免疫缺陷及其治疗:超越免疫球蛋白治疗
Pulm Circ. 2025 Jan 1;15(1):e70034. doi: 10.1002/pul2.70034. eCollection 2025 Jan.
2
Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report.普通变异性免疫缺陷伴肉芽肿性淋巴细胞性间质性肺病和先前的神经受累:一例报告。
BMC Pulm Med. 2020 Jul 31;20(1):205. doi: 10.1186/s12890-020-01231-6.
3
Clinical and immunological features of 44 common variable immunodeficiency patients: the experience of a single center in Turkey.44 例常见变异性免疫缺陷患者的临床和免疫学特征:土耳其某单一中心的经验。
Allergol Immunopathol (Madr). 2020 Nov-Dec;48(6):675-685. doi: 10.1016/j.aller.2019.12.008. Epub 2020 Apr 13.
4
Pulmonary Hypertension in Patients with Common Variable Immunodeficiency.普通可变免疫缺陷患者的肺动脉高压
J Clin Immunol. 2021 Oct;41(7):1549-1562. doi: 10.1007/s10875-021-01064-w. Epub 2021 Jun 10.
5
Common Variable Immunodeficiency and Liver Involvement.常见可变免疫缺陷与肝脏受累。
Clin Rev Allergy Immunol. 2018 Dec;55(3):340-351. doi: 10.1007/s12016-017-8638-z.
6
Investigating pulmonary and non-infectious complications in common variable immunodeficiency disorders: a UK national multi-centre study.研究普通可变免疫缺陷病中的肺部和非感染性并发症:一项英国全国多中心研究。
Front Immunol. 2024 Sep 10;15:1451813. doi: 10.3389/fimmu.2024.1451813. eCollection 2024.
7
Common variable immunodeficiency and its inflammatory neurological manifestations: A case report and literature review.常见变异性免疫缺陷及其炎症性神经表现:病例报告及文献复习。
Mult Scler Relat Disord. 2022 Nov;67:104086. doi: 10.1016/j.msard.2022.104086. Epub 2022 Aug 1.
8
Differentiation of Common Variable Immunodeficiency From IgG Deficiency.普通变异性免疫缺陷与 IgG 缺乏症的鉴别。
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1277-1284. doi: 10.1016/j.jaip.2018.12.004. Epub 2018 Dec 14.
9
Common variable immunodeficiency disorder-related liver disease is common and results in portal hypertension and an increased risk of death.常见变异型免疫缺陷相关肝病较为常见,可导致门静脉高压和死亡风险增加。
Hepatol Commun. 2023 Dec 15;8(1). doi: 10.1097/HC9.0000000000000322. eCollection 2024 Jan 1.
10
Rituximab and improved nodular regenerative hyperplasia-associated non-cirrhotic liver disease in common variable immunodeficiency: a case report and literature study.利妥昔单抗与常见可变免疫缺陷相关结节性再生性增生性非肝硬化性肝病的改善:病例报告及文献研究。
Front Immunol. 2023 Sep 19;14:1264482. doi: 10.3389/fimmu.2023.1264482. eCollection 2023.

本文引用的文献

1
New Drugs and Therapies in Pulmonary Arterial Hypertension.新型药物和疗法在肺动脉高压中的应用。
Int J Mol Sci. 2023 Mar 19;24(6):5850. doi: 10.3390/ijms24065850.
2
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
3
Successful Treatment of Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with CTLA-4 Deficiency.CTLA-4 缺陷患者的肉芽肿性淋巴细胞性间质性肺病的成功治疗。
Intern Med. 2023 Mar 15;62(6):871-875. doi: 10.2169/internalmedicine.0076-22. Epub 2022 Aug 10.
4
Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial.INCREASE 试验中吸入曲前列尼尔治疗特发性肺纤维化相关性肺动脉高压患者多疾病进展事件的疗效。
Am J Respir Crit Care Med. 2022 Jan 15;205(2):198-207. doi: 10.1164/rccm.202107-1766OC.
5
Pulmonary hypertension: A rare but severe complication of common variable immunodeficiency.肺动脉高压:常见可变免疫缺陷的一种罕见但严重的并发症。
Ann Allergy Asthma Immunol. 2021 Oct;127(4):512-513. doi: 10.1016/j.anai.2021.06.016.
6
Therapeutic options for CTLA-4 insufficiency.CTLA-4 不足的治疗选择。
J Allergy Clin Immunol. 2022 Feb;149(2):736-746. doi: 10.1016/j.jaci.2021.04.039. Epub 2021 Jun 7.
7
Pulmonary Hypertension in Patients with Common Variable Immunodeficiency.普通可变免疫缺陷患者的肺动脉高压
J Clin Immunol. 2021 Oct;41(7):1549-1562. doi: 10.1007/s10875-021-01064-w. Epub 2021 Jun 10.
8
Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic Review.常见可变免疫缺陷中的 GLILD 的治疗策略:系统评价。
Front Immunol. 2021 Apr 15;12:606099. doi: 10.3389/fimmu.2021.606099. eCollection 2021.
9
Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers.普通变异性免疫缺陷病(CVID)相关肉芽肿性淋巴细胞性间质性肺病(GLILD):意大利 PID 转诊中心患者的多中心回顾性研究。
Front Immunol. 2021 Mar 10;12:627423. doi: 10.3389/fimmu.2021.627423. eCollection 2021.
10
Bronchiectasis is associated with delayed diagnosis and adverse outcomes in the New Zealand Common Variable Immunodeficiency Disorders cohort study.支气管扩张症与新西兰常见可变免疫缺陷疾病队列研究中延迟诊断和不良结局相关。
Clin Exp Immunol. 2021 Jun;204(3):352-360. doi: 10.1111/cei.13595. Epub 2021 Apr 12.